Placebo (matched to VX-993)

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Acute PainDiabetic Peripheral Neuropathic Pain

Phase 2

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

RecruitingNCT06619860

Vertex Pharmaceuticals IncorporatedDiabetic Peripheral Neuropathic Pain

Start: 2024-10-18End: 2026-05-30Target: 300Updated: 2026-03-16

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

CompletedNCT06619847

Vertex Pharmaceuticals IncorporatedAcute Pain

Start: 2024-10-29End: 2025-05-27Updated: 2025-06-26